ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


SEARCH JOBS








 Company News
Hemispherx Biopharma (HEB) Announces New Publication Enlarges The Understanding Of Ampligen® Safety Profile Across Diverse Animal Species And Focuses On The Unique TLR-3 Receptor/Ampligen(R) Interaction 4/8/2014 7:31:48 AM    More...
Hemispherx Biopharma (HEB) Presented Clinical Interpretations On CFS Treatment At The 11th Biennial International Research And Clinical Conference 3/24/2014 8:52:31 AM    More...
Hemispherx Biopharma (HEB) To Present Clinical Interpretations On CFS Treatment At The 11th Biennial International Research And Clinical Conference 3/19/2014 9:48:33 AM    More...
Hemispherx Biopharma (HEB) Announces Plans To File For Regulatory Approval Of Ampligen® To Treat Chronic Fatigue Syndrome (CFS) In Three Additional Latin America Countries 3/11/2014 9:20:31 AM    More...
Hemispherx Biopharma (HEB) Wins Federal Lawsuit Regarding Investment Banking Fees 3/10/2014 9:51:04 AM    More...
Hemispherx Biopharma (HEB) Publishes Full National Press Club Presentation On Corporate Website 2/24/2014 8:47:27 AM    More...
Hemispherx Biopharma (HEB) Summarizes Clinical Results Presented In Washington, DC On January 30, 2014 In Conjunction With The American Society for Microbiology Biodefense Conference Aimed At Developing A Universal Influenza Vaccine To Prevent Pandemic Influenza Threat 2/4/2014 9:04:51 AM    More...
Hemispherx Biopharma (HEB) Release: A Clinical Update On The Search For A Universal Flu Vaccine: Presentation In Washington, DC On January 30, 2014 In Conjunction With The American Society of Microbiology Biodefense Conference 1/28/2014 9:08:19 AM    More...
Hemispherx Biopharma (HEB) And Researchers With The University of Alabama at Birmingham To Discuss Clinical Trial Studies Aimed At Developing A Universal Influenza Vaccine To Prevent Pandemic Influenza Threat 1/27/2014 10:42:54 AM    More...
Hemispherx Biopharma (HEB) Analysis Of New Data On Protection From Pulmonary Damage Associated With Infection By Highly Pathogenic Influenza Virus 1/22/2014 8:50:30 AM    More...
12345678910...